How does raloxifene influence the effects of growth hormone replacement

Phase 4

Active, not recruiting

• Conditions: Hypopituitary women; Metabolic and Endocrine - Other metabolic and endocrine disorders

• Registration Number: ACTRN12605000532606
• Lead Sponsor: Department of Endocrinology, St Vincents Hospital Sydney

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-09-28
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: Female
• Target Recruitment: 12

Inclusion Criteria

Hypopituitarism (deficient in growth hormone and sex steroids).

Exclusion Criteria

No exclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified